This study examines the effects of prostaglandin I 2 (PGI 2 ) on urokinase-type plasminogen activator (uPA) production and wound healing by human fibroblasts. Employing fibrin autography, it was found that beraprost sodium, a stable PGI 2 analog, enhanced the fibrinolytic activity in media conditioned by human fibroblasts, TIG-3-20 cells. Fibrin zymography, ELISA, and Northern blot analysis confirmed that the enhanced activity was caused by an increase in uPA synthesis and secretion and a decrease in type-1 plasminogen activator inhibitor. While cycloheximide and 2P,5P-dideoxyadenosine, an adenylate cyclase inhibitor, suppressed the effect of PGI 2 , dibutyryl cyclic AMP increased the fibrinolytic activity and uPA mRNA. These findings indicate that PGI 2 promotes uPA production in TIG-3-20 cells via direct stimulation of the cyclic AMP intracellular pathway. A similar effect was observed in two other fibroblast cell lines, TIG-7-20 and TIG-7-30. Although PGI 2 itself did not affect cellular proliferation, it promoted in vitro repopulation of the denuded area in a wounded monolayer. These observations suggest that PGI 2 can stimulate wound healing through the enhanced production of uPA. z 1998 Elsevier Science B.V.
Introduction
Wound healing involves extensive cellular migration and tissue remodeling during the processes of reepithelialization, wound contraction, and angiogenesis [1, 2] . Interactions between the cells and extracellular matrix are central to these processes and are likely to require both degradation and rebuilding of matrix molecules.
Plasminogen activators are serine proteases that play a role in pericellular proteolysis, participating in cellular migration, tumor invasion, and thrombolysis [3^6] . Whereas tissue-type plasminogen activator (tPA) has been associated primarily with ¢brinolysis, urokinase-type plasminogen activator (uPA) is involved in tissue remodeling and cellular migration under both normal and pathological conditions, including cancer and in£ammatory reactions. During in vivo wound re-epithelialization, uPA has been shown to localize at the leading edge of migrating keratinocytes [7^9] . Plasmin, uPA, and metalloproteinases may also a¡ect the release and activation of growth factors embedded in the extracellular matrix [10^12] .
Prostaglandins (PGs) and other metabolites of arachidonic acid are associated with hemostasis due to their e¡ects on blood platelets. Platelet aggregation and secretion may be controlled by a balance between antiaggregatory PGI 2 , which is produced primarily by the blood vessels wall, and proaggregatory thromboxane A 2 , which is produced primarily by the platelets themselves [13, 14] . Since PGI 2 is a vasodilator and thromboxane A 2 a vasoconstrictor [15] , they may also in£uence blood £ow and vessel patency through their opposing e¡ects on vascular tone.
Interleukin-1, tumor necrosis factor, epidermal growth factor, and platelet-derived growth factor are known to be present during the process of wound healing. They play important roles in the angiogenesis and chemotaxis of macrophages and ¢broblasts [16, 17] and promote PGI 2 synthesis in endothelial cells, macrophages, and smooth muscle cells [182 2] . It is thus possible that PGI 2 may be produced during wound healing and a¡ect the cellular functions.
In the present study, we used beraprost sodium, a stable PGI 2 analog [23, 24] , to assess the e¡ects of PGI 2 on ¢brinolytic activity produced by cultured human ¢broblasts and the process of wound healing.
Materials and methods

Materials
Beraprost sodium was kindly provided by Kaken (Kyoto, Japan). Dulbecco's modi¢ed Eagle's medium (DMEM), penicillin, streptomycin, and amphotericin B were purchased from Gibco (Grand Island, NY). Fetal bovine serum was purchased from EquitechBio (Ingram, TX). Dibutyryl cAMP (DBcAMP), cycloheximide, 2P,5P-dideoxyadenosine (DDA), and actinomycin D were purchased from American Diagnostica (Greenwich, CT).
Human uPA probe was prepared as described previously [25] . The uPA gene fragment (from +5433 to +6148 in exon XI) was ¢rst ampli¢ed by the PCR, and the resulting product was employed as a template for a second PCR. The ¢nal product showed a single 0.7-kb band in agarose gel and was used as the uPA probe. Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) cDNA probe was purchased from Clontech (Palo Alto, CA).
Cell cultures
The Japanese Cancer Research Resources Bank provided the human embryonic lung ¢broblast cell lines, TIG-3-20, TIG-7-20, and TIG-7-30. These cells were cultured to con£uence in either 12-well microtiter plates or 50-mm Petri dishes containing DMEM supplemented with 10% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 Wg/ml) at 37³C under 5% CO 2 and 95% humidity. After incubation with various reagents, the conditioned media were collected and stored at 370³C until being assayed.
Fibrin autography
The gross ¢brinolytic activity in the conditioned media of human ¢broblasts was assayed employing ¢brin gel plates containing 5 mg/ml bovine ¢brinogen (Miles, Kankakee, IL), and 1 U/ml bovine thrombin (Mochida Pharmaceutical, Tokyo, Japan). After being loaded with 30 Wl of each sample, the ¢brin plate was allowed to develop at 37³C.
Fibrin zymography
Following harvesting of the conditioned media, we performed SDS-polyacrylamide gel electrophoresis using 10% acrylamide gels according to the procedure of Laemmli [26] . Human high molecular weight uPA (American Diagnostica, Greenwich, CT) and single chain tPA (American Diagnostica, Greenwich, CT) were run in parallel as standards. After electrophoresis, the SDS gels were soaked in 2.5% Triton X-100 for 1 h to remove the SDS. The gels were then applied to the surface of a ¢brin agar indicator gel containing 1.0% agarose, 20 Wg/ml plasminogen, 1 U/ ml thrombin, and 4 mg/ml ¢brinogen, and allowed to develop at 37³C.
Measurement of uPA and PAI-1 antigen levels
The antigen levels of uPA and type-1 plasminogen activator inhibitor (PAI-1) in the conditioned media were measured by ELISA (TintElize uPA and PAI-1 Kit, Biopool Meditech, Ventura, CA) according to the manufacturer's instructions.
2.6. RNA isolation and Northern blot analysis for uPA mRNA
The total RNA was isolated from TIG-3-20 cells after treatment with guanidinium isothiocyanate^sar-cosyl solution followed by phenol extraction and ethanol precipitation. For Northern blot analysis, 5 Wg RNA per lane was electrophoresed through 1% formaldehyde agarose gels and then transferred to a nylon membrane (Amersham, Buckinghamshire, UK). Hybridization was performed employing a Gene Images Random Prime Labeling and Detection System (Amersham, South Clearbrook, IL) according to the manufacturer's instructions. Hybridization was carried out using a £uorescein-labeled uPA probe. Following incubation overnight at 65³C, the membrane was washed in 1USSC^0.1% SDS at 65³C followed by a second wash in 0.1USSC^0.1% SDS at 65³C. The membrane was then blocked and incubated with an anti-£uorescein alkaline phosphatase conjugate. After washing o¡ the excess conjugate, the membrane was used to catalyze light production through the enzymatic decomposition of a stabilized dioxetane substrate. The membrane was subsequently utilized for autography. After removing the uPA probe, the membrane was rehybridized employing a GAPDH probe under the same experimental conditions. The relative levels of mRNA signals on the autoradiograms were quanti¢ed by image analysis (BioMax 1D Image Analysis, Eastman Kodak, Rochester, NY), and the results were expressed as the ratio of mRNA to GAPDH mRNA.
Proliferation assay
Approximately the same numbers of TIG-3-20 cells were seeded per well into a 96-well, £at-bottom, microtiter plate and cultured in a standard medium. After 1 day, 1.0 Wg/ml PGI 2 was added to the culture medium. Untreated cultures served as the controls.
Following reincubation for 1^2 days, the cell numbers were measured using a cell counting kit (Wako, Osaka, Japan). A tetrazolium salt, 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST-1) [27] , was then added, bringing the ¢nal concentration in each well to 5 mM, and the plates were incubated for 2 h at 37³C. The optical density at 405 nm was determined with a microtiter plate reader (Model 450, Bio-Rad, Hercules, CA).
Migration assay in wound healing
As a model of wound healing, wounds were produced mechanically by scraping a plastic brush across con£uent TIG-3-20 cells [28] . After wounding, the cultures were incubated in media containing 1.0 Wg/ml PGI 2 . The control culture media contained no additives. The migration of cells into the wounded area was observed over a 3-day period employing phase contrast microscopy. Fig. 1 shows the time course of ¢brinolytic activity in media conditioned by TIG-3-20 cells following incubation with 1.0 Wg/ml PGI 2 . After 3 h, lysis by the PGI 2 -stimulated cells increased greatly, with a pronounced di¡erence being evident between the PGI 2 -stimulated cells and the control at 12 h of in- Fig. 1 . Time course of beraprost induction of ¢brinolytic activity by TIG-3-20 cells as evaluated by ¢brin autography. TIG-3-20 cell lines were cultured to a con£uent state in 12-well microtiter plates. After incubation for various periods with 1.0 Wg/ml beraprost or with DMEM alone, 30 Wl of each of the conditioned media was loaded onto the ¢brin gel containing 5 mg/ml bovine ¢brinogen, 1 U/ml bovine thrombin and 20 Wg/ml human plasminogen. After 16 h incubation at 37³C, the lysis of the ¢brin gel was observed.
Results
E¡ect of PGI 2 on ¢brinolytic activity produced by ¢broblasts
cubation. It was con¢rmed that TIG-3-20 cells exhibited ¢brinolytic activity and that the activity was enhanced by PGI 2 .
To determine whether the increased ¢brinolytic activity was due to tPA or uPA, ¢brin zymography was carried out (Fig. 2) . After incubation with varying concentrations of PGI 2 for 12 h, the conditioned media were examined as described above. The lytic zone corresponded to the standard marker and was con¢rmed as uPA. This uPA activity was enhanced by PGI 2 , with the maximum increase in lysis occurring at a PGI 2 concentration of 1.0 Wg/ml. The uPA antigen levels were then measured by ELISA (Fig. 3) . PGI 2 stimulation of uPA secretion was detected at a concentration of 0.01 Wg/ml, with maximum uPA secretion being evident at 1.0 Wg/ml, where an approximately 2.5-fold increase was observed. Based on these results, a PGI 2 concentration of 1.0 Wg/ml was used for subsequent experiments.
The PAI-1 antigen levels were also measured by ELISA (Fig. 4) . PGI 2 stimulation of PAI-1 demonstrated just the opposite e¡ect to that for the uPA antigen levels. The PAI-1 antigen levels decreased at a PGI 2 concentration of 0.001 Wg/ml and were minimal at a concentration of 1.0 Wg/ml, where a decrease of approximately 70% was observed.
To evaluate the participation of cyclic AMP in uPA stimulation by PGI 2 , we examined the e¡ects of DBcAMP, a cyclic AMP analog, and DDA, an adenylate cyclase inhibitor. After a 12-h incubation, the conditioned media were analyzed by ¢brin zymography (Fig. 5) . While the ¢brinolytic activity with DBcAMP increased to an identical level to the PGI 2 -induced activity, DDA apparently suppressed the e¡ect. These results imply that cyclic AMP plays a role in the stimulation of uPA by PGI 2 .
To determine whether or not new protein synthesis After incubation with various concentrations of beraprost for 12 h, each of the conditioned media was observed by ¢brin zymography as described in Section 2. t, tPA; 1, control; 2, 0.001 Wg/ml beraprost; 3, 0.01 Wg/ml beraprost; 4, 0.1 Wg/ml beraprost; 5, 1.0 Wg/ml beraprost; 6, 10 Wg/ml beraprost ; u, uPA.
is required for uPA stimulation by PGI 2 , we examined the e¡ects of cycloheximide, an inhibitor of cellular protein synthesis, and actinomycin D, an inhibitor of RNA synthesis. The ¢brinolytic activity in the media conditioned by PGI 2 -treated cells that had received either cycloheximide or actinomycin D was analyzed by ¢brin zymography (Fig. 5) . While the ¢brinolytic activity in the PGI 2 -treated cells increased, the addition of either cycloheximide or actinomycin D suppressed the ¢brinolytic activity to the level of the control, suggesting that gene expression of uPA is required for the e¡ects of PGI 2 to be observed. We also investigated the e¡ect of PGI 2 on the ¢brinolytic activity in two other human ¢broblast cell lines, TIG-7-20 and TIG-7-30. After a 12-h incubation with 1.0 Wg/ml PGI 2 , all conditioned media were evaluated by ¢brin autography. The ¢brinolytic activity increased in all PGI 2 -treated cells in comparison with the controls (Fig. 6 ).
E¡ect of PGI 2 on uPA mRNA level
To con¢rm PGI 2 stimulation of uPA protein synthesis, uPA mRNA was measured using Northern blot analysis. mRNA reached its maximum level at 1 h and then declined (Fig. 7A) . When compared according to the ratio of mRNA to GAPDH mRNA, the relative uPA mRNA level increased to approximately 20-fold that of the control (Fig. 7B) , After incubation with various reagents for 12 h, each of the conditioned media was observed by ¢brin zymography. t, tPA; 1, 250 WM DBcAMP; 2, 1.0 Wg/ml beraprost+100 WM DDA ; 3, control ; 4, 1.0 Wg/ml beraprost; 5, 1.0 Wg/ml beraprost+10 Wg/ml cycloheximide; 6, 1.0 Wg/ml beraprost+10 Wg/ml actinomycin D; u, uPA.
indicating that PGI 2 promotes uPA protein synthesis in TIG-3-20 cells.
In addition, we examined the e¡ects of cycloheximide, DBcAMP, and DDA by Northern blot analysis. After a 1-h incubation of TIG-3-20 cells treated with each reagent, the total RNA was extracted and analyzed for uPA mRNA. When the cells were incubated with cycloheximide, the uPA mRNA level increased, rising even higher on treatment with cycloheximide supplemented with PGI 2 (Fig.  8 ). With DDA, the level dropped. When the cells were incubated with DBcAMP, the level increased to the same value as that for the PGI 2 -stimulated cells, con¢rming the in£uence of cAMP on the uPA mRNA levels. Fig. 10 . E¡ect of beraprost on wound healing. Con£uent TIG-3-20 cells were wounded mechanically by scraping with a plastic brush. After incubation with or without 1.0 Wg/ml beraprost, the migration of the cells into the wounded area was observed by phase contrast microscopy over a period of 72 h. 8 . E¡ects of cycloheximide, DBcAMP, and DDA on uPA mRNA expression in TIG-3-20 cells. The total RNA was isolated from TIG-3-20 cells stimulated with various reagents for 1 h. Sequentially, the RNA was subjected to Northern blot analysis. 1 and 5, control ; 2 and 6, 1.0 Wg/ml beraprost; 3, 10 Wg/ml cycloheximide; 4, 1.0 Wg/ml beraprost+10 Wg/ml cycloheximide ; 7, 200 WM DBcAMP; 8, 1.0 Wg/ml beraprost+200 WM DDA.
E¡ect of PGI 2 on cellular proliferation
To determine the e¡ect of PGI 2 on TIG-3-20 cellular proliferation, a PGI 2 concentration of 1.0 Wg/ml was added to TIG-3-20 cells in a non-con£uent state. After 1^2 days, the numbers of cells were measured employing the WST-1 Uptake Assay. When the TIG-3-20 cultures were grown in the presence of PGI 2 , the proliferation rate did not di¡er from that of the control cultures (Fig. 9) , indicating that PGI 2 does not a¡ect cellular proliferation.
E¡ect of PGI 2 on cellular migration during wound healing
As outlined above, wounds were produced mechanically by scraping a plastic brush across con£u-ent TIG-3-20 cells. The migration of cells into the wounded area was monitored over a 3-day period by phase contrast microscopy. We observed repopulation of the denuded area leading to full closure of the wound in the presence of PGI 2 . Over the 3-day period, repopulation of the denuded area was stimulated by the presence of PGI 2 as compared with the controls (Fig. 10) . These results indicate that PGI 2 can stimulate cellular migration and subsequent wound healing.
Discussion
Recent studies have shown that the plasminogenp lasmin system is involved in wound healing. Either uPA or tPA has been detected at the leading edge of migrating keratinocytes [7, 8, 29] , ¢broblasts [29] , microvascular endothelial cells [30] , and corneal epithelial cells [31] . In addition, enhanced expression of uPA and PAI-1 mRNA has been observed in endothelial cells and renal epithelial cells at the edge of the wound [32, 33] . Based on immunohistochemical studies and in situ hybridization, uPA has been identi¢ed during in vivo experiments involving re-epithelialization of mouse and human skin wounds [9, 34, 35] . In addition to playing a role in proteolytic degradation of the extracellular matrix, uPA may also serve as a chemotaxin or a mitogen [36^38] . Further research has indicated that uPA and plasmin may a¡ect cytokine release and activity [39, 40] .
Although the precise role of uPA is not fully understood, accumulated evidence suggests the importance of uPA in wound healing.
To date, several interactions between PGs and the ¢brinolytic system have been described. PGE 1 and PGE 2 increase ¢brinolytic activity by stimulating plasminogen activator production in various cell types including ovarian granuloma cells [41] , human foreskin ¢broblasts [42] , embryonic lung ¢broblasts [43] , osteoblasts [44] , and endometrial stromal cells [45] . Although Crutchley et al. reported that PGI 2 stimulated the ¢brinolytic activity in human foreskin ¢broblasts [42] , they did not speci¢cally identify the agent responsible for this increased ¢brinolytic activity.
In our study, we demonstrated that PGI 2 enhances uPA secretion and synthesis by human embryonic ¢broblasts, TIG-3-20. Since PGI 2 is very unstable with a half-life of 5^10 min in aqueous solution, we employed the stable PGI 2 analog, beraprost sodium, which has been reported to exhibit an identical e¡ect to PGI 2 on platelet aggregation and vasodilation [23, 24] . As shown in Fig. 1, PGI 2 enhanced the ¢bri-nolytic activity in human ¢broblasts. Using ¢brin zymography (Fig. 2) and ELISA (Fig. 3) , this increased activity was con¢rmed to be due to uPA. In addition, it was demonstrated by Northern blot analysis (Fig. 7) that PGI 2 promoted uPA synthesis. The secretion and synthesis of uPA were suppressed by both cycloheximide and actinomycin D (Figs. 5 and 8), indicating that the e¡ect of PGI 2 on uPA expression does not require de novo protein synthesis. DBcAMP, as well as PGI 2 , increased the ¢brino-lytic activity in ¢broblasts, while DDA suppressed the e¡ect of PGI 2 (Figs. 5 and 8 ). Similar ¢ndings were also obtained for other human ¢broblast cell lines (Fig. 6) . From these results, we conclude that PGI 2 enhances uPA synthesis in ¢broblasts via direct stimulation of the cyclic AMP intracellular pathway. This is consistent with the fact that PGI 2 stimulates the cyclic AMP levels in human ¢broblasts [46] .
Recent studies have con¢rmed that PGE 2 stimulates corneal endothelial wound healing [47, 48] and bone resorption in osteosarcoma cells [49] . To our knowledge, there has been no previous report concerning the e¡ect of PGI 2 on wound healing. Although in our experiments, PGI 2 promoted cellu-lar migration during wound healing in vitro (Fig.  10 ), PGI 2 itself had no e¡ect on cellular proliferation (Fig. 9) . Rather, the observed cellular proliferation may have been the result of an interaction between the migrating cells and the extracellular matrix remaining after the cultures had been removed, or could have resulted from activating growth factors or releasing growth factors in the extracellular matrix.
Wounds cause damage to limited numbers of epithelial and connective tissue cells. The wounded area immediately ¢lls with clotted blood containing ¢brin and blood cells. Subsequently, neutrophils, endothelial cells, and macrophages migrate towards the ¢brin clot where they grow, thereby leading to wound healing. Since such cells are known to produce PGI 2 by stimulating various cytokines and growth factors [19^22] , PGI 2 may be supplied to ¢broblasts during all phases of wound healing.
Clinically, PGI 2 analog is used for chronic artery obstruction disease and is known to be e¡ective in healing skin ulcers. Although this e¡ect is thought to be the result of an improved peripheral circulation through vasodilation, our study raises the possibility that PGI 2 may directly a¡ect wound healing by stimulating uPA production in human ¢bro-blasts.
In addition, we have observed that the expression of uPA receptor is enhanced in PGI 2 -stimulated ¢-broblasts (data not shown). The uPA receptor is a cell-surface protein which plays an important role in the regulation and location of uPA-catalyzed extracellular matrix degradation [50] . Our ¢ndings provide a new insight into the possible role of PGI 2 in the regulation of pericellular proteolysis during wound healing.
